Inherent, a British AI startup founded by former DeepMind researchers, unveiled Faraday, an AI agent designed to replicate scientific research. The company claims Faraday outperformed systems from Anthropic and OpenAI at reproducing findings from published papers, positioning the tool as a step toward automating scientific discovery.
The replication of research represents a different challenge than standard benchmarks. When scientists publish papers, they often omit implementation details, use proprietary datasets, or describe methods vaguely enough that reproduction requires problem-solving and inference. Faraday tackles this by operating as an autonomous agent that reads papers, identifies missing information, formulates hypotheses about what the authors likely did, and then implements and tests solutions to validate results.
This approach matters because research reproducibility remains a systemic problem across fields. Studies show that many published findings cannot be replicated by independent teams. This crisis undermines scientific progress and wastes resources. If AI can reliably reconstruct research from papers alone, it accelerates validation cycles and helps identify flawed or fraudulent work faster.
Faraday's benchmark performance against Anthropic's Claude and OpenAI's systems suggests Inherent built something genuinely useful rather than overhyped. Replication tests measure real-world capability more fairly than abstract reasoning tasks. The agent needs to reason through ambiguity, write functional code, design experiments, and iterate when initial attempts fail. These demands mirror what human scientists actually do.
DeepMind's influence on Inherent runs deep. The lab's alumni brought expertise in reinforcement learning and agentic AI systems, fields where DeepMind holds significant advantages. That foundation likely accelerated development of an agent capable of handling open-ended scientific tasks rather than closed-domain problems.
What happens next depends on adoption. If Inherent can deploy Faraday to major research institutions or integrate it into academic publishing workflows, the impact scales quickly. Universities and labs could use the system to validate submissions before publication. Publishers might run Faraday against new papers as a quality gate. Researchers could automate parts of literature review and methodology validation.
Commercialization paths exist too. Pharma companies and biotech firms spend billions validating competitor research and reproducing external findings for regulatory purposes. Faraday cuts that cost substantially. Materials science, chemistry, and machine learning research all depend on reproducible methods. Any field with expensive, time-consuming experiments sees value in faster verification.
Risks deserve mention. Over-reliance on AI replication could mask genuine novelty if the system settles for approximate matches rather than exact reproduction. False confidence in automated validation could suppress healthy skepticism. The system works only as well as the papers it reads, so poorly written research remains opaque.
Inherent operates in a crowded space. Anthropic, OpenAI, and other labs also develop reasoning-focused AI agents. The difference here centers on specialization. Faraday targets a specific, measurable problem with clear performance metrics. Generalist models rarely beat specialized tools at narrowly defined tasks.
The broader narrative concerns AI's role in accelerating human research. DeepMind's AlphaFold cracked protein folding structure prediction. Inherent targets the messier problem of converting published descriptions into working implementations. If successful, Faraday becomes a tool that amplifies researcher productivity across disciplines.